Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. DIAZEPAM RENAUDIN (diazépam)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

DIAZEPAM RENAUDIN (diazépam)

Medicine - Posted on Jul 26 2024
Active substance (DCI)
  • diazépam
history (2)
  • 6/12/24

    DIAZEPAM RENAUDIN (diazepam) - Premedication

    Summary of opinion Unfavourable opinion for reimbursement in premedication before endoscopy in adults. ...
    CAV :
    54321
    icône flèche
  • 11/30/16

    DIAZEPAM RENAUDIN (diazépam)

    Mise à disposition d’une présentation en boîte de 10 ampoules de 2 ml en complément de la présentation en boîte de 100 ampou...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • N05BA01
Manufacturer
RENAUDIN
Presentation

DIAZEPAM RENAUDIN 10 mg/2 ml, solution injectable (code CIS : 61569856) 
10 ampoule(s) en verre de 2 ml (CIP : 34009 358 146 3 0)

All our publications
    Anaesthesia, sedation, analgesia Anxiety and neurotic disorders Bacterial infections Central nervous system diseases Drug therapy Emergency treatment and intensive care Paediatrics Substance-related disorders

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
29c08t6EaXMbc4Ne